In conclusion, EA may serve as an effective therapeutic approach for enhancing hormone levels and reproductive function in individuals with PCOS by modulating the HPO axis and the kisspeptin-GnRH/LH axis. This evidence concerns the gene GFER and polycystic ovary syndrome.